Article Details
Retrieved on: 2021-12-03 11:06:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 11,725,344 shares of the biopharmaceutical company's stock valued at $454,826,000 after purchasing an additional 600,968 ...
Article found on: etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here